NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every industry reaches a moment when proof stops being optional. For SMX (NASDAQ:SMX), that moment has arrived. What began as molecular science has ...
NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every company reaches a turning point when its technology stops being promise and starts becoming structure. SMX (NASDAQ:SMX) is there now. The ...
Also included in cash used in operations for the third quarter of 2025 is inventory financing payments of $1,378,000 for golf cart purchases of Venom under our financing agreement, which is expected ...
“Completing the first cohort is an important milestone as we progress toward demonstrating the potential clinical benefits of CMND-100 for people living with alcohol use disorder,” said Dr. Adi Zuloff ...